Lawsuit: Mylan’s epic EpiPen price hike wasn’t about greed—it’s worse

Ars Technica » Scientific Method 2017-04-29

Summary:

With higher prices, Mylan allegedly dangled deep discounts—if buyers excluded rival.

Link:

https://arstechnica.com/science/2017/04/lawsuit-mylans-epic-epipen-price-hike-wasnt-about-greed-its-worse/

From feeds:

Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific Method

Tags:

Authors:

Beth Mole

Date tagged:

04/29/2017, 08:22

Date published:

04/25/2017, 17:58